182 related articles for article (PubMed ID: 24729544)
1. Inhibition of cathepsin activity in a cell-based assay by a light-activated ruthenium compound.
Respondek T; Sharma R; Herroon MK; Garner RN; Knoll JD; Cueny E; Turro C; Podgorski I; Kodanko JJ
ChemMedChem; 2014 Jun; 9(6):1306-15. PubMed ID: 24729544
[TBL] [Abstract][Full Text] [Related]
2. New Ru(ii) complex for dual photochemotherapy: release of cathepsin K inhibitor and
Rohrabaugh TN; Collins KA; Xue C; White JK; Kodanko JJ; Turro C
Dalton Trans; 2018 Aug; 47(34):11851-11858. PubMed ID: 29741184
[TBL] [Abstract][Full Text] [Related]
3. Study of the biological activity of photoactive bipyridyl-Ru(II) complexes containing 1,3,5-triaza-7-phosphaadamantane (PTA).
Del Pino JMV; Scalambra F; Bermejo-Casadesús C; Massaguer A; García-Maroto F; Romerosa A
J Inorg Biochem; 2023 Sep; 246():112291. PubMed ID: 37352655
[TBL] [Abstract][Full Text] [Related]
4. Light activation of a cysteine protease inhibitor: caging of a peptidomimetic nitrile with Ru(II)(bpy)2.
Respondek T; Garner RN; Herroon MK; Podgorski I; Turro C; Kodanko JJ
J Am Chem Soc; 2011 Nov; 133(43):17164-7. PubMed ID: 21973207
[TBL] [Abstract][Full Text] [Related]
5. Preparation, stability, and photoreactivity of thiolato ruthenium polypyridyl complexes: Can cysteine derivatives protect ruthenium-based anticancer complexes?
van Rixel VH; Busemann A; Göttle AJ; Bonnet S
J Inorg Biochem; 2015 Sep; 150():174-81. PubMed ID: 26187140
[TBL] [Abstract][Full Text] [Related]
6. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium nitrosyl complexes with 1,4,7-trithiacyclononane and 2,2'-bipyridine (bpy) or 2-phenylazopyridine (pap) coligands. Electronic structure and reactivity aspects.
De P; Maji S; Chowdhury AD; Mobin SM; Mondal TK; Paretzki A; Lahiri GK
Dalton Trans; 2011 Dec; 40(46):12527-39. PubMed ID: 21986798
[TBL] [Abstract][Full Text] [Related]
8. Ruthenium-Cathepsin Inhibitor Conjugates for Green Light-Activated Photodynamic Therapy and Photochemotherapy.
Denison M; Garcia SP; Ullrich A; Podgorski I; Gibson H; Turro C; Kodanko JJ
Inorg Chem; 2024 Apr; 63(17):7973-7983. PubMed ID: 38616353
[TBL] [Abstract][Full Text] [Related]
9. Ruthenium tris(2-pyridylmethyl)amine as an effective photocaging group for nitriles.
Sharma R; Knoll JD; Martin PD; Podgorski I; Turro C; Kodanko JJ
Inorg Chem; 2014 Apr; 53(7):3272-4. PubMed ID: 24661182
[TBL] [Abstract][Full Text] [Related]
10. Targeting telomeric G-quadruplexes with the ruthenium(II) complexes [Ru(bpy)(2)(ptpn)](2+) and [Ru(phen)(2)(ptpn)](2+).
Chen X; Wu JH; Lai YW; Zhao R; Chao H; Ji LN
Dalton Trans; 2013 Apr; 42(13):4386-97. PubMed ID: 23400220
[TBL] [Abstract][Full Text] [Related]
11. A novel azopyridine-based Ru(II) complex with GSH-responsive DNA photobinding ability.
Zhou QX; Zheng Y; Wang TJ; Chen YJ; Li K; Zhang YY; Li C; Hou YJ; Wang XS
Chem Commun (Camb); 2015 Jul; 51(53):10684-6. PubMed ID: 26051473
[TBL] [Abstract][Full Text] [Related]
12. Imaging Sites of Inhibition of Proteolysis in Pathomimetic Human Breast Cancer Cultures by Light-Activated Ruthenium Compound.
Ramalho SD; Sharma R; White JK; Aggarwal N; Chalasani A; Sameni M; Moin K; Vieira PC; Turro C; Kodanko JJ; Sloane BF
PLoS One; 2015; 10(11):e0142527. PubMed ID: 26562785
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of Bipyridine and Coordination with Nitrosyl: Cyclometalated Ruthenium Nitrosyl Complex.
Wu Y; Wang Y; Sun Y; Li Z; Li X; Zhou Z; Tang D
Inorg Chem; 2022 Jun; 61(24):8997-9011. PubMed ID: 35657382
[TBL] [Abstract][Full Text] [Related]
14. [Ru(bpy)2(5-cyanouracil)2]2+ as a potential light-activated dual-action therapeutic agent.
Garner RN; Gallucci JC; Dunbar KR; Turro C
Inorg Chem; 2011 Oct; 50(19):9213-5. PubMed ID: 21879748
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of ruthenium(II)-oligopyridine-peptide conjugates. Interactions of the diasteromeres Δ- and Λ-[Ru(bpy)2(4-COY-4'-Mebpy)]Cl2 (Y=Gly-Lys(1)-Lys(2)CONH2, Lys(1)-Gly-Lys(2)CONH2, Lys(1)-Lys(2)-GlyCONH2) with the oligonucleotide d(5'-CGCGAATTCGCG-3')2.
Karidi K; Ypsilantis K; Papakyriakou A; Garoufis A
J Inorg Biochem; 2013 Oct; 127():13-23. PubMed ID: 23838117
[TBL] [Abstract][Full Text] [Related]
16. Electronic structure of oxidized complexes derived from cis-[Ru(II)(bpy)2(H2O)2]2+ and its photoisomerization mechanism.
Planas N; Vigara L; Cady C; Miró P; Huang P; Hammarström L; Styring S; Leidel N; Dau H; Haumann M; Gagliardi L; Cramer CJ; Llobet A
Inorg Chem; 2011 Nov; 50(21):11134-42. PubMed ID: 21992177
[TBL] [Abstract][Full Text] [Related]
17. Upconversion Nanocarriers Encapsulated with Photoactivatable Ru Complexes for Near-Infrared Light-Regulated Enzyme Activity.
Chen Z; Thiramanas R; Schwendy M; Xie C; Parekh SH; Mailänder V; Wu S
Small; 2017 Dec; 13(46):. PubMed ID: 29024342
[TBL] [Abstract][Full Text] [Related]
18. Photoactivated inhibition of cathepsin K in a 3D tumor model.
Herroon MK; Sharma R; Rajagurubandara E; Turro C; Kodanko JJ; Podgorski I
Biol Chem; 2016 Jun; 397(6):571-82. PubMed ID: 26901495
[TBL] [Abstract][Full Text] [Related]
19. A ruthenium(II) arene complex showing emission enhancement and photocleavage activity towards DNA from singlet and triplet excited states respectively.
Chen Y; Lei W; Jiang G; Zhou Q; Hou Y; Li C; Zhang B; Wang X
Dalton Trans; 2013 Apr; 42(16):5924-31. PubMed ID: 23459918
[TBL] [Abstract][Full Text] [Related]
20. Substituent effect and wavelength dependence of the photoinduced Ru-O homolysis in the [Ru(bpy)2(py-SO3)](+)-type complexes.
Zheng Y; Zhou QX; Zhang YY; Li C; Hou YJ; Wang XS
Dalton Trans; 2016 Feb; 45(7):2897-905. PubMed ID: 26752625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
